Position in RXRX
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$71,748
+$33,066 QoQ
Shares Held
19,550
+55.2% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#208
of 340 holders
Holding Since
Mar 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RXRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Moors & Cabot, Inc. holds $4,203,874 across 8 Biotechnology names. RXRX ranks #6 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,390 | $1,683,914 | |
| 2 | MRNA |
Moderna, Inc.
|
14,616 | $1,023,558 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
2,330 | $570,314 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
645 | $402,183 | |
| 5 | CRSP |
CRISPR Therapeutics AG
|
6,732 | $367,163 | |
| 6 | RXRX |
Recursion Pharmaceuticals, Inc.
This page
|
19,550 | $71,748 | |
| 7 | IMRX |
Immuneering Corp
|
10,000 | $49,900 | |
| 8 | NGEN |
Nervgen Pharma Corp.
|
17,036 | $35,094 |
All Filings in RXRX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $71,748 | 19,550 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $38,682 | 12,600 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $113,497 | 27,750 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $139,792 | 28,646 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $225,423 | 44,550 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $232,072 | 43,870 | Shares | Sole | 2025-05-08 | |
| 2024-03-31 | $134,595 | 13,500 | Shares | Sole | 2024-05-08 | |
| No filing history on record for this holder in this stock. | ||||||